Title : In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells.

Pub. Date : 2020

PMID : 32566390






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our results suggest SECO as a novel P-gp inhibitor that can re-sensitize cancer cells during DOX chemotherapy. Doxorubicin ATP binding cassette subfamily B member 1 Homo sapiens